[1]
«COVID-19 AND INTELLECTUAL PROPERTY LAW: COMPULSORY LICENSING AND THE ACCESS TO COVID-19 TREATMENT », De Legibus, n.º 1, p. 16, out. 2021, doi: 10.53456/dlb.vi1.7556.